Towards the disease biomarker in an individual patient using statistical health monitoring.

In metabolomics, identification of complex diseases is often based on application of (multivariate) statistical techniques to the data. Commonly, each disease requires its own specific diagnostic model, separating healthy and diseased individuals, which is not very practical in a diagnostic setting....

Full description

Bibliographic Details
Main Authors: Jasper Engel, Lionel Blanchet, Udo F H Engelke, Ron A Wevers, Lutgarde M C Buydens
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3972152?pdf=render
id doaj-e3cd6b99283d43dd86c430bc6221af08
record_format Article
spelling doaj-e3cd6b99283d43dd86c430bc6221af082020-11-24T21:50:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9245210.1371/journal.pone.0092452Towards the disease biomarker in an individual patient using statistical health monitoring.Jasper EngelLionel BlanchetUdo F H EngelkeRon A WeversLutgarde M C BuydensIn metabolomics, identification of complex diseases is often based on application of (multivariate) statistical techniques to the data. Commonly, each disease requires its own specific diagnostic model, separating healthy and diseased individuals, which is not very practical in a diagnostic setting. Additionally, for orphan diseases such models cannot be constructed due to a lack of available data. An alternative approach adapted from industrial process control is proposed in this study: statistical health monitoring (SHM). In SHM the metabolic profile of an individual is compared to that of healthy people in a multivariate manner. Abnormal metabolite concentrations, or abnormal patterns of concentrations, are indicated by the method. Subsequently, this biomarker can be used for diagnosis. A tremendous advantage here is that only data of healthy people is required to construct the model. The method is applicable in current-population based -clinical practice as well as in personalized health applications. In this study, SHM was successfully applied for diagnosis of several orphan diseases as well as detection of metabotypic abnormalities related to diet and drug intake.http://europepmc.org/articles/PMC3972152?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Jasper Engel
Lionel Blanchet
Udo F H Engelke
Ron A Wevers
Lutgarde M C Buydens
spellingShingle Jasper Engel
Lionel Blanchet
Udo F H Engelke
Ron A Wevers
Lutgarde M C Buydens
Towards the disease biomarker in an individual patient using statistical health monitoring.
PLoS ONE
author_facet Jasper Engel
Lionel Blanchet
Udo F H Engelke
Ron A Wevers
Lutgarde M C Buydens
author_sort Jasper Engel
title Towards the disease biomarker in an individual patient using statistical health monitoring.
title_short Towards the disease biomarker in an individual patient using statistical health monitoring.
title_full Towards the disease biomarker in an individual patient using statistical health monitoring.
title_fullStr Towards the disease biomarker in an individual patient using statistical health monitoring.
title_full_unstemmed Towards the disease biomarker in an individual patient using statistical health monitoring.
title_sort towards the disease biomarker in an individual patient using statistical health monitoring.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description In metabolomics, identification of complex diseases is often based on application of (multivariate) statistical techniques to the data. Commonly, each disease requires its own specific diagnostic model, separating healthy and diseased individuals, which is not very practical in a diagnostic setting. Additionally, for orphan diseases such models cannot be constructed due to a lack of available data. An alternative approach adapted from industrial process control is proposed in this study: statistical health monitoring (SHM). In SHM the metabolic profile of an individual is compared to that of healthy people in a multivariate manner. Abnormal metabolite concentrations, or abnormal patterns of concentrations, are indicated by the method. Subsequently, this biomarker can be used for diagnosis. A tremendous advantage here is that only data of healthy people is required to construct the model. The method is applicable in current-population based -clinical practice as well as in personalized health applications. In this study, SHM was successfully applied for diagnosis of several orphan diseases as well as detection of metabotypic abnormalities related to diet and drug intake.
url http://europepmc.org/articles/PMC3972152?pdf=render
work_keys_str_mv AT jasperengel towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring
AT lionelblanchet towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring
AT udofhengelke towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring
AT ronawevers towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring
AT lutgardemcbuydens towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring
_version_ 1725884092307734528